STAT+: Ultragenyx cuts staff after another study fails
· statnews.com · popularity 34/100 · 0 similar stories today
Read the original at statnews.com →
Summary
Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 1.